Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06241963
Other study ID # AHMU-tDCS-epilepsy
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 12, 2024
Est. completion date June 30, 2026

Study information

Verified date February 2024
Source Anhui Medical University
Contact Kai Wang, PhD
Phone +86-0551-62923704
Email wangkai1964@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To observe the clinical effect and safety of transcranial electrical stimulation on patients with refractory epilepsy before and after treatment and analyze its therapeutic mechanism.


Description:

All participants underwent a medical evaluation that included physical examination and routine laboratory studies before and after high definition transcranial direct current stimulation (HD-tDCS) treatment.Upon meeting the inclusion criteria and providing informed consent, each participant will complete clinical assessments by a trained investigator and HD-tDCS treatment at Anhui mental health centre. At least 90 participants were randomized (1:1:1) to receive "bilateral active" ,"Unilateral active" or "Sham" treatment protocol. The left electrical stimulation cathode was placed over CP5 with return electrodes placed at FT7, C1, P03 and P9 . The right electrical stimulation cathode was placed over CP6 with return electrodes placed at FT8, C2, PO4 and P10 . In the bilateral treatment group, HD-tDCS treatment was placed on the left and right sides of the brain, at least eight hours apart. Twenty 2-mA sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 30 minutes,twice a day over 10 consecutive workdays. In the unilateral treatment group, HD-tDCS treatment based on Epileptic discharge is placed on either the left or right side of the brain.Ten 2-mA sessions were applied for 30 minutes,once a day over 10 consecutive workdays.Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds. Before and after the tDCS treatment, the patients had receiving a battery measure of neuropsychological tests, Magnetic resonance imaging scan in multimodalities, VEEG and Resting motor threshold. The clinical symptom of participants were followed 4 weeks and 12 weeks after the last treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date June 30, 2026
Est. primary completion date December 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Clinical diagnosis of refractory epilepsy - Right-handed and aged 18-50 years old and primary school education or above; - No major neurological or mental illness, no head injury, alcohol dependence or drug dependence; - During the experiment, the subjects did not smoke, drink, get sick and take psychotropic drugs, and there were no major life events that caused mood changes. Exclusion Criteria: - organic brain injury, neurological diseases or serious physical diseases; - Have a history of substance abuse and drug dependence, or have used antipsychotic drugs in the past three months, and have serious suicidal tendencies; - There are contraindications for MRI or EEG or transcranial magnetic stimulation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Active Comparator: Unilateral real High definition transcranial direct current stimulation
Improvement of cortical excitability, unilateral stimulation was effective, and no side effects were observed
Active Comparator: Bilateral real High definition transcranial direct current stimulation
Improved cortical excitability, the effect was more obvious than unilateral stimulation, the effect lasted longer, and no side effects were observed
Sham Comparator: Sham High definition transcranial direct current stimulation
The sham stimulation is mainly used for blank control, control variables, and exclude the interference of other factors

Locations

Country Name City State
China Anhui Medical University Hefei Anhui

Sponsors (1)

Lead Sponsor Collaborator
Anhui Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The changes of Epilepsy diary The reduction of seizure frequency in patients with epilepsy will constitute the primary outcome measure to evaluate the efficacy of HD-tDCS, reflecting the improvement of patients' clinical symptoms. Patients and family members are asked to keep an epilepsy diary to record the time, duration, and status of the seizure. Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of VEEG The number of discharges recorded by VEEG before and after the intervention, as well as the decrease in epileptiform discharge index, were used as indicators to evaluate the improvement of epilepsy symptoms Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of resting-state functional connectivity the change of resting-state functional connectivity strength between stimulated target and the whole brain areas will be measured by functional MRI and resting-state EEG. Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of resting motor threshold(RMT) Previous studies have found that the resting movement threshold is an effective measure of cortical excitability in epilepsy patients, and can better predict the therapeutic effect. An elevated resting movement threshold indicates that the treatment is responding. Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of glutamate receptor-mediated intracortical facilitation (ICF) ICF is a 120% RMT stimulation administered 15 ms after 90% RMT intensity stimulation, glutamate receptor-mediated intracortical promotion Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of GABA-A receptor-mediated short septal cortical inhibition (SICI) SICI is 120% RMT administered 4 ms after 80% RMT intensity stimulation in response to GABA-A receptor-mediated short-interval cortical inhibition Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of GABA-B receptor-mediated long septal cortical inhibition (LICI). LICI is 120% RMT administered 150ms after 120% RMT intensity stimulation in response to GABA-A receptor-mediated long-interval cortical inhibition, Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of MoCA Score MoCA was developed by Nasreddine et al. based on clinical experience and reference to the MMSE cognitive items and scores, and the final version was finalized in November 2004. We adopted a localized version (Mandarin version,includes 2 alternative versions) in line with the Chinese cultural background.A higher score indicates improvement Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of Hamilton Depression Rating Scale (HAMD) Score The HAMD is a clinic ian-administered depression assessment and consists of 17 items with a total score range from 0 to 54. A higher score indicates a worse outcome. Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of Hamilton Anxiety Scale (HAMA) Score The HAMA is a 14-item scale to measure the severity of anxiety symptoms, where each item is rated on a scale from 0 to 4. The HAMA total score ranges from 0 to 56, with lower scores indicating less anxiety symptoms. Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of Chinese auditory learning test Score A group consists of 15 words, read to the subject at a speed of one per second, after reading, let the patient repeat these 15 words, record the number of words spoken correctly, repeat the above behavior five times, start the timer after the end, let the patient recall 15 words after 30 minutes, and calculate the correct number,The more vocabulary is memorized, the better the score Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of TMT (Trail Making Test) Score The Trail Making Test (TMT) is divided into two parts, part A and part B. Part A requires the subject to connect 25 Numbers on the paper in sequence, and part B requires the subject to connect 25 Numbers of different colors alternately in sequence. The time it takes for the subject to complete all the Numbers is the subject's final score.the shorter the better. Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
Secondary The changes of Face associative memory Score The associative memory was estimated using a face-cued word association test. In the face-cued word association test, participants studied 20 human face photographs presented individually in grayscale on a computer screen for 4 s per face. Each photograph displayed a unique common word that the participants read aloud as each face-word pair was shown. The participants were instructed to memorize the word associated with each face. After the face-word pairs were presented, participants were shown the same 20 faces, individually and in a different and randomized order. They were asked to recall the words that were presented with each face. Each face was scored as correct or incorrect. These processes are carried out 2 times in total. The average number of successful answers was defined as the associative memory score.The more faces you remember correctly, the higher your score. Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
See also
  Status Clinical Trial Phase
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Completed NCT04504344 - Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After Anterior Cruciate Ligament Reconstruction Phase 1
Recruiting NCT06148363 - Intervention Effect of High-Definition Transcranial Direct Current Stimulation (HD-tDCS) on Non-suicidal Self-injury (NSSI) N/A
Recruiting NCT06193278 - Individual Neuromodulation for PDS N/A
Active, not recruiting NCT05293431 - Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic N/A
Recruiting NCT04997226 - Cognitive Enhancement in Healthy Elderly People N/A
Active, not recruiting NCT04159012 - NESBID: Neuro-Stimulation of the Brain in Depression N/A
Completed NCT04226417 - Effect of Home Based Transcranial Direct Current Stimulation (tDCS) With Exercise on Upper and Lower Limb Motor Functions in Chronic Stroke N/A
Active, not recruiting NCT02959502 - Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression N/A
Not yet recruiting NCT05467566 - Transcranial Direct Current Stimulation Combined With Exercise in Low Back Pain N/A
Completed NCT03050385 - Cognitive Rehabilitation During Transcranial Direct Current Stimulation N/A
Completed NCT02287207 - Effects of Transcranial Direct Current Stimulation on Fine Motor Skills in Parkinson's Disease: a Pilot Study N/A
Recruiting NCT03635008 - Anodal Transcranial Direct Current Stimulation Over the Contralesional Hemisphere on Motor Recovery in Subacute Stroke Patients N/A
Completed NCT04117256 - Transcranial Versus Suboccipital Direct Current Stimulation N/A
Completed NCT04328545 - Transcranial Direct Current Stimulation Effect on Pain Threshold and Working Memory: Impact of Age and Protocol Type N/A
Completed NCT04697901 - Sustaining Aviator Performance During Extended Operational Flight N/A
Active, not recruiting NCT03655769 - fMRI Analysis of Aging and Awareness in Conditioning N/A
Completed NCT03680664 - Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS) N/A
Recruiting NCT04052399 - Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance N/A
Completed NCT06110936 - Effects of Transcutaneous Spinal Direct Current Stimulation on Mobility in Cases With Multiple Sclerosis N/A